Search companies

Live

Tuesday, 17 November 2026 · 580 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Xenitra Returns To Quarterly Gross Profit As Pharmaceuticals Launch

Xenitra Limited (XEN) · Consumer discretionary

XEN: $0.002 +0.00% · MC: $14M

Xenitra reported positive quarterly gross profit, reversing a loss in the same quarter last year, as its newly operational pharmaceuticals division generated approximately $864,000 in sales. The company says its three-year procurement agreements provide for at least $12 million in purchases and target a further $5 million, while Web3 partnerships have supported more than $2 million in sales since April. Quarter-end bank cash rose 9% from June and more than doubled year on year to approximately $3 million.

Source announcements: 2026-10-30 16:37 to 2026-10-30 16:37 Sydney time
Story updated 2026-10-30 16:42 Sydney time
SourcesQuarterly Activities/Appendix 4C Cash Flow Report
Comments